| Gene symbol | AR | Synonyms | AIS, AR8, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq12 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | androgen receptor | ||||
| GTO ID | GTC1794 |
| Trial ID | NCT03300505 |
| Disease | Prostate Cancer |
| Altered gene | AR |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | AZD5312|ISIS 560131|ARRx |
| Co-treatment | Enzalutamide |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | ARRO-CITO: (UMCC 2017.055) Phase Ib/II Single-Arm Multi-Center Study of IONIS-AR-2.5Rx, a Next Generation Androgen Receptor Antisense Oligonucleotide, in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer |
| Year | 2019 |
| Country | United States |
| Company sponsor | University of Michigan Rogel Cancer Center |
| Other ID(s) | UMCC 2017.055|HUM00130051 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||